BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19520679)

  • 41. Inherited thrombophilia in infertile women: implication in unexplained infertility.
    Casadei L; Puca F; Privitera L; Zamaro V; Emidi E
    Fertil Steril; 2010 Jul; 94(2):755-7. PubMed ID: 19939360
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Do thrombophilic gene mutations have a role on thromboembolic events in cancer patients?
    Ozkan M; Sivgin S; Kocyigit I; Emirogullari F; Dikilitas M; Kaynar L; Ozkul Y; Er O
    Asia Pac J Clin Oncol; 2012 Sep; 8(3):e34-41. PubMed ID: 22898008
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factor V Leiden, prothrombin G20210A and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms and the risk of tamoxifen-associated thromboembolism in breast cancer patients.
    Eroğlu A; Akar N
    Thromb Res; 2011 Apr; 127(4):384-5. PubMed ID: 21093891
    [No Abstract]   [Full Text] [Related]  

  • 44. Genetic polymorphisms in venous thrombosis and pulmonary embolism after total hip arthroplasty: a pilot study.
    Ringwald J; Berger A; Adler W; Kraus C; Pitto RP
    Clin Orthop Relat Res; 2009 Jun; 467(6):1507-15. PubMed ID: 18800213
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Concomitant heterozygous factor V Leiden mutation and homozygous prothrombin gene variant (G20210A) in patient with cerebral venous thrombosis.
    Kurkowska-Jastrzebska I; Wicha W; Dowzenko A; Vertun-Baranowska B; Pytlewski A; Bogusławska R; Członkowska A
    Med Sci Monit; 2003 May; 9(5):CS41-5. PubMed ID: 12761462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ocular vascular thrombotic events: a diagnostic window to familial thrombophilia (compound factor V Leiden and prothrombin gene heterozygosity) and thrombosis.
    Glueck CJ; Wang P
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):12-8. PubMed ID: 18796459
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Venous thromboembolism in young women; role of thrombophilic mutations and oral contraceptive use.
    Legnani C; Palareti G; Guazzaloca G; Cosmi B; Lunghi B; Bernardi F; Coccheri S
    Eur Heart J; 2002 Jun; 23(12):984-90. PubMed ID: 12069454
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations among patients with sickle cell disease in Eastern Saudi Arabia.
    Fawaz NA; Bashawery L; Al-Sheikh I; Qatari A; Al-Othman SS; Almawi WY
    Am J Hematol; 2004 Jul; 76(3):307-9. PubMed ID: 15224376
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation.
    Margaglione M; D'Andrea G; d'Addedda M; Giuliani N; Cappucci G; Iannaccone L; Vecchione G; Grandone E; Brancaccio V; Di Minno G
    Thromb Haemost; 1998 May; 79(5):907-11. PubMed ID: 9609218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of genetic and acquired prothrombotic risk factors in genesis of sudden sensorineural hearing loss.
    Fusconi M; Chistolini A; Angelosanto N; Pignoloni P; Tombolini M; De Virgilio A; Pagliarella M; de Vincentiis M
    Audiol Neurootol; 2011; 16(3):185-90. PubMed ID: 20798492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations.
    Grandone E; Margaglione M; Colaizzo D; D'Andrea G; Cappucci G; Brancaccio V; Di Minno G
    Am J Obstet Gynecol; 1998 Nov; 179(5):1324-8. PubMed ID: 9822524
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls.
    Simone B; De Stefano V; Leoncini E; Zacho J; Martinelli I; Emmerich J; Rossi E; Folsom AR; Almawi WY; Scarabin PY; den Heijer M; Cushman M; Penco S; Vaya A; Angchaisuksiri P; Okumus G; Gemmati D; Cima S; Akar N; Oguzulgen KI; Ducros V; Lichy C; Fernandez-Miranda C; Szczeklik A; Nieto JA; Torres JD; Le Cam-Duchez V; Ivanov P; Cantu-Brito C; Shmeleva VM; Stegnar M; Ogunyemi D; Eid SS; Nicolotti N; De Feo E; Ricciardi W; Boccia S
    Eur J Epidemiol; 2013 Aug; 28(8):621-47. PubMed ID: 23900608
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cerebral sinovenous thrombosis associated with factor V Leiden and methylenetetrahydrofolate reductase A1298C mutation in adult membranous glomerulonephritis.
    Ozkurt S; Temiz G; Saylisoy S; Soydan M
    Ren Fail; 2011; 33(5):524-7. PubMed ID: 21500982
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Site of venous thromboembolism and prothrombotic mutations according to body mass index. Results from the EDITH study.
    Delluc A; Le Moigne E; Tromeur C; Noel-Savina E; Couturaud F; Mottier D; Le Gal G; Lacut K
    Br J Haematol; 2011 Aug; 154(4):486-91. PubMed ID: 21671893
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factor V Leiden and pulmonary embolism in a young woman taking an oral contraceptive.
    DiSiena MR; Intres R; Carter DJ
    Am J Forensic Med Pathol; 1998 Dec; 19(4):362-7. PubMed ID: 9885932
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased Factor V Leiden frequency is associated with venous thrombotic events among young Brazilian patients.
    de Paula Sabino A; Guimarães DA; Ribeiro DD; Paiva SG; Sant'Ana Dusse LM; das Graças Carvalho M; Fernandes AP
    J Thromb Thrombolysis; 2007 Dec; 24(3):261-6. PubMed ID: 17401546
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of prothrombotic mutations on factor consumption in children with hemophilia.
    Tüten H; Çam H; Özdemir N; Bezgal F; Buyru N; Zülfikar B; Celkan T
    Clin Appl Thromb Hemost; 2013; 19(4):445-8. PubMed ID: 22411997
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigation on genetic thrombophilic factors in FFPE autopsy tissue from subjects who died from pulmonary embolism.
    Brandimarti F; Alessandrini F; Pesaresi M; Catalani C; De Angelis L; Galeazzi R; Giovagnetti S; Gesuita R; Righi E; Giorgetti R; Tagliabracci A
    Int J Legal Med; 2017 Mar; 131(2):447-458. PubMed ID: 27933413
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factor V Leiden, prothrombin G20210A substitution and hormone therapy: indications for molecular screening.
    Andreassi MG; Botto N; Maffei S
    Clin Chem Lab Med; 2006; 44(5):514-21. PubMed ID: 16681418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism.
    Jun ZJ; Ping T; Lei Y; Li L; Ming SY; Jing W
    Clin Lab Haematol; 2006 Apr; 28(2):111-6. PubMed ID: 16630215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.